Wound Care Innovations (WCI), a wholly owned subsidiary of Wound Management Technologies, Inc. was formed with the sole purpose of introducing and distributing a truly unique and innovative solution to the greater than $2.5 billion domestic US wound care market - Cellerate. WCI is the exclusive distributor of a line of ACTIVATED COLLAGEN wound care products featuring a patented molecular form of collagen called Cellerate. The Company's immediate market is with primary buyers including healthcare providers (physicians, clinics, hospitals, homecare, long term care and DME), and a vast secondary consumer market. WCI's line of Activated Collagen-based products are all FDA cleared as medical devices and have been cleared for use in the management of chronic & acute wounds and skin ulcers.
This product is cleared by the FDA as a medical device and is made in the USA.
For additional information on Wound Management Technologies, Inc., please visit www.wmgtech.com.
Specialties
Advanced Wound Care Products
